PLK1 and hepatocellular carcinoma: The results showed that PLK1 inhibitors specially induces the G2/M phase arrest of HCC cells carrying TERT mutation after 24 and 72 h treatment while wild‐type cells remained unchanged (Figures 3A, S2A and S3A).